Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04155723
Other study ID # GHBretagneSud
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 6, 2019
Est. completion date June 1, 2023

Study information

Verified date July 2023
Source Groupe Hospitalier de Bretagne Sud
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The administration of medication, fluid resuscitation, or even nutrition in intensive care unit (ICU) patients, requires one or more infusion lines which can be peripheral or central. Midline catheter is a 10 to 20 cm long peripheral venous catheter, which can be used for up to 28 days. These features make it a good alternative to central venous and conventional peripheral venous catheters. Midlines are routinely used in the ICU of Lorient Hospital, currently inserted by doctors. In association with the Regional Health Agency, the investigators are currently implementing a project of task delegation to ICU nurses, so that they could insert Midlines' catheters. The aim of the study is to increase the use of Midlines in the unit to reduce the exposure to central venous catheters and their complications, such as infections or thrombosis. The investigators propose to conduct a prospective monocentric study to compare the frequency of Midlines'use, before and after the task delegation. The primary objective is to compare the duration of exposure to central venous catheters between the two periods. Secondary objectives are to compare the duration of exposure to peripheral venous catheters and Midlines, and the catheter-related infections and thrombosis.


Description:

The administration of medication, fluid resuscitation, or even nutrition in intensive care unit (ICU) patients, requires one or more infusion lines which can be peripheral or central. Although central venous catheters (CVC) are often mandatory in ICU, the risk of catheter-related infections should lead to consider the insertion of peripheral venous catheters. However in ICU patients, presence of edema or poor venous condition may not allow placement of peripheral venous catheter. Midline catheter is a 10 to 20 cm long peripheral venous catheter, which can be used for up to 28 days (according to manufacturer recommendations). These features make it a good alternative to central venous and conventional peripheral venous catheters. They are placed at the bedside, peripherally into the cephalic or basilic vein, with the tip reaching the axillary vein. Midlines are routinely used in the ICU of Lorient Hospital, currently inserted by doctors. Studies have shown the feasibility and the safety of delegating to nurses placement of CVC and Midlines. In association with the Regional Health Agency, the investigators are currently implementing a project of task delegation to ICU nurses, so that they could insert Midlines' catheters. Midlines' implementation has been associated with a decrease in the use of CVC and catheter-related infections. To our knowledge, no study investigated the placement of Midlines by nurses in the ICU. The investigators propose to conduct a prospective monocentric study to compare the frequency of Midlines' use, before and after the task delegation. The primary objective is to compare the duration of exposure to central venous catheters between the two periods. Secondary objectives are to compare the duration of exposure to peripheral venous catheters and Midlines, and the catheter-related infections and thrombosis. Complications related to Midlines' placement would also be recorded.


Recruitment information / eligibility

Status Completed
Enrollment 310
Est. completion date June 1, 2023
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult patients hospitalized in ICU for more than 48 hours Exclusion Criteria: - Patient under 18 years old - Patient under legal guardianship - Absence of health insurance in France - Refusal of the patient or his next-of-kin - Patient with a decision of withholding or withdrawing of life sustaining therapy - Patient with a subcutaneous central venous port - Impossibility of infusion on the upper limbs

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Groupe Hospitalier Bretagne Sud Lorient

Sponsors (1)

Lead Sponsor Collaborator
Groupe Hospitalier de Bretagne Sud

Country where clinical trial is conducted

France, 

References & Publications (6)

Alexandrou E, Spencer TR, Frost SA, Mifflin N, Davidson PM, Hillman KM. Central venous catheter placement by advanced practice nurses demonstrates low procedural complication and infection rates--a report from 13 years of service*. Crit Care Med. 2014 Mar;42(3):536-43. doi: 10.1097/CCM.0b013e3182a667f0. — View Citation

O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S; Healthcare Infection Control Practices Advisory Committee. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011 May;39(4 Suppl 1):S1-34. doi: 10.1016/j.ajic.2011.01.003. No abstract available. — View Citation

Pathak R, Gangina S, Jairam F, Hinton K. A vascular access and midlines program can decrease hospital-acquired central line-associated bloodstream infections and cost to a community-based hospital. Ther Clin Risk Manag. 2018 Aug 21;14:1453-1456. doi: 10.2147/TCRM.S171748. eCollection 2018. — View Citation

Pathak R, Patel A, Enuh H, Adekunle O, Shrisgantharajah V, Diaz K. The Incidence of Central Line-Associated Bacteremia After the Introduction of Midline Catheters in a Ventilator Unit Population. Infect Dis Clin Pract (Baltim Md). 2015 May;23(3):131-134. doi: 10.1097/IPC.0000000000000237. — View Citation

Shokoohi H, Boniface K, McCarthy M, Khedir Al-tiae T, Sattarian M, Ding R, Liu YT, Pourmand A, Schoenfeld E, Scott J, Shesser R, Yadav K. Ultrasound-guided peripheral intravenous access program is associated with a marked reduction in central venous catheter use in noncritically ill emergency department patients. Ann Emerg Med. 2013 Feb;61(2):198-203. doi: 10.1016/j.annemergmed.2012.09.016. Epub 2012 Nov 7. — View Citation

Xu T, Kingsley L, DiNucci S, Messer G, Jeong JH, Morgan B, Shutt K, Yassin MH. Safety and utilization of peripherally inserted central catheters versus midline catheters at a large academic medical center. Am J Infect Control. 2016 Dec 1;44(12):1458-1461. doi: 10.1016/j.ajic.2016.09.010. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Duration of exposure to central venous catheter Duration of exposure to central venous catheter (catheter-days per patient-day) ICU discharge (usually seven days)
Secondary Duration of exposure to peripheral venous catheter Duration of exposure to peripheral venous catheter (catheter-days per patient-day) ICU discharge (usually seven days)
Secondary Duration of exposure to Midline Duration of exposure to Midline (catheter-days per patient-day) ICU discharge (usually seven days)
Secondary Number of catheter-related infections Number of catheter-related infections (number of events per 1000 catheter days) ICU discharge (usually seven days)
Secondary Number of catheter-related infections Number of catheter-related infections (number of events per 1000 catheter days) Hospital discharge (usually two weeks)
Secondary Number of catheter-related thrombosis Number of catheter-related thrombosis (number of events per 1000 catheter days) ICU discharge (usually seven days)
Secondary Number of catheter-related thrombosis Number of catheter-related thrombosis (number of events per 1000 catheter days) Hospital discharge (usually two weeks)
Secondary Number of pneumothorax and arterial punctures Number of pneumothorax and arterial punctures (for each catheter inserted, percentage) ICU discharge (usually seven days)
Secondary Number of patients discharged from the ICU with a central venous catheter Number of patients discharged from the ICU with a central venous catheter (percentage) ICU discharge (usually seven days)
Secondary Description of the events associated with Midlines' insertion : Number of punctures Number of punctures (per Midline inserted) ICU discharge (usually seven days)
Secondary Description of the events associated with Midlines' insertion : Duration of the procedure Duration of the procedure (in minutes) ICU discharge (usually seven days)
Secondary Description of the events associated with Midlines' insertion : Failure rate Failure rate (percentage) ICU discharge (usually seven days)
See also
  Status Clinical Trial Phase
Terminated NCT04787926 - DuraLock-C Catheter Lock Solution
Active, not recruiting NCT02515201 - Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children Phase 4
Recruiting NCT04140916 - Comparison of Two Peripheral Inserted Intravenous Catheters N/A
Not yet recruiting NCT06019897 - Impact of Tubing Colonization on the Incidence of Central Venous Catheter Infection
Completed NCT02970409 - Heparin Versus Saline in Peripheral Venous Catheter N/A
Completed NCT03101371 - Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion Phase 2
Completed NCT04821193 - Comparison of the Effects of 5%NaHCO3, 2%CHG and 70%Alcohol in the Prevention of Infections Related to Catheter N/A
Completed NCT02577718 - Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock Solution Phase 1/Phase 2
Completed NCT02279121 - ATAPAC Study (TauroLock Activity in Adult Cancer Patients) N/A
Completed NCT00965198 - Comparison of Infection Rates Among Patients Using Two Catheter Access Devices N/A
Recruiting NCT05741866 - Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs) N/A
Recruiting NCT04825314 - Noble Meta Alloy Coated Catheters in Patients With Long Term Catheterization N/A
Active, not recruiting NCT03945045 - A Study of the IJV or the SCV Approach for Ultrasound-guided Implantation of TIVAD N/A
Active, not recruiting NCT01592032 - Concentration of Antimicrobials in Catheter-lock Solutions Phase 4
Terminated NCT04906512 - Comparing CHG I.V. Securement Dressing With Transparent Dressing for Evaluation of Antimicrobial Efficacy N/A
Withdrawn NCT02899780 - Treatment of Infected Dialysis Catheters With Fiber Optic Ultraviolet Light N/A
Recruiting NCT05995080 - The Effectiveness of Chlorhexidine Gluconate on Prevention of Catheter-Related Bloodstream Infections N/A
Completed NCT04794231 - Comparison of Chlorhexidine Impregnated Dressing and Standard Dressing N/A
Terminated NCT03447639 - Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal Phase 4
Completed NCT03950921 - Pilot Testing a Patient Safety Display in the Hospital Setting N/A